Atea Pharmaceuticals(AVIR)
Search documents
Atea Pharmaceuticals(AVIR) - 2021 Q4 - Earnings Call Transcript
2022-03-01 03:28
Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q4 2021 Earnings Conference Call February 28, 2022 4:30 PM ET Company Participants Jonae Barnes - SVP, IR and Corporate Communications Jean-Pierre Sommadossi - Founder and CEO Janet Hammond - Chief Development Officer Andrea Corcoran - CFO and EVP, Legal John Vavricka - Chief Commercial Officer Conference Call Participants Matthew Harrison - Morgan Stanley Lachlan Hanbury-Brown - William Blair Roanna Ruiz - SVB Leerink Operator Good afternoon, ladies and gentlemen we ...
Atea Pharmaceuticals(AVIR) - 2021 Q3 - Earnings Call Transcript
2021-11-12 04:18
Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q3 2021 Earnings Conference Call November 11, 2021 4:30 PM ET Company Participants Jonae Barnes - Senior Vice President of Investor Relations & Corporate Communications Jean-Pierre Sommadossi - Founder, Chairman & Chief Executive Officer Janet Hammond - Chief Development Officer Andrea Corcoran - Chief Financial Officer & Executive Vice President of Legal Conference Call Participants Jonathan Miller - Evercore ISI Tim Lugo - William Blair Roanna Ruiz - SVB Leerink Op ...
Atea Pharmaceuticals(AVIR) - 2021 Q2 - Earnings Call Transcript
2021-08-13 02:58
Call Start: 16:30 January 1, 0000 5:08 PM ET Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q2 2021 Earnings Conference Call August 12, 2021 04:30 PM ET Company Participants Jonae Barnes - SVP, Investor Relations and Corporate Communications Jean-Pierre Sommadossi - Founder, Chairman and CEO Janet Hammond - Chief Development Officer Andrea Corcoran - CFO and EVP, Legal John Vavricka - Chief Commercial Officer Conference Call Participants Eric Joseph - J.P. Morgan Jonathan Miller - Evercore Lachlan Hanbury-Brown - ...